In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seismic Therapeutic, Inc., the machine learning immunology company, today announced that it has closed a $121 million Series B financing. The Series B was led by new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results